Press Release Archives

	2008 Press Releases 07/23/08   Conceptus Reports Sharply Higher Second Quarter Net Sales of $25.7 Million 07/10/08   Conceptus to Hold 2008 Second Quarter Financial Results Conference Call July 23, 2008 05/28/08   Conceptus to Present at the 7th Annual Needham & Company Biotechnology and Medical Technology Conference 05/14/08   Conceptus to Present at the 7th Annual JMP Securities Research Conference 05/12/08   Essure Procedure Now Covered by Medicaid in California 05/06/08   Conceptus® Reports First Quarter Net Sales Up 53% 04/21/08   Conceptus to Hold 2008 First Quarter Financial Results Conference Call May 6, 2008 02/28/08   Conceptus to Present at the Cowen and Company's 28th Annual Health Care Conference 02/21/08   Conceptus Hires Todd Sloan as Vice President of Marketing 02/20/08   Conceptus to Present at the Raymond James 29th Annual Institutional Investors Conference 02/19/08   Conceptus Reports Fourth Quarter Financial Results 02/06/08   Conceptus to Hold 2007 Fourth Quarter Financial Results Conference Call February 19, 2008 01/08/08   Conceptus Introduces 2008 Financial Guidance, Updates 2007 Guidance 01/03/08   Conceptus to Introduce 2008 Guidance and Update 2007 Guidance 2007 Press Releases 11/30/07   Health Canada Approves Conceptus' Third Generation Essure® Permanent Birth Control System 11/19/07   Three New In-office Studies on Essure® Procedure Presented at AAGL Meeting, including First Study on Third-generation System 11/06/07   More than 20 New Studies Show the Many Benefits of Essure® Compared with Surgical Tubal Ligation 11/06/07   Conceptus to Present at the Stephens Inc. Fall Investment Conference 10/30/07   Conceptus to Present at CIBC World Markets Healthcare Conference 10/25/07   Conceptus Reports Third Quarter Net Sales of $16.4 Million 10/11/07   Conceptus to Hold 2007 Third Quarter Financial Results Conference Call October 25, 2007 10/10/07   Conceptus Hires Spencer Roeck as Vice President of International 09/13/07   Conceptus to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007 08/01/07   Women Find Conceptus’ Essure Permanent Birth Control Procedure Less Painful Than Tubal Ligation in a New Study 07/25/07   FDA Approves Conceptus’ Third Generation Essure® Permanent Birth Control System 07/25/07   Conceptus Second Quarter Net Sales Increase 57% TO $15.7 Million 07/12/07   Conceptus to Hold 2007 Second Quarter Financial Results Conference Call July 25, 2007 05/11/07   Conceptus To Present At The 6th Annual JMP Securities Research Conference 05/10/07   Conceptus Hires Darrin Uecker as Vice President, R&D and Operations 05/07/07   Conceptus Celebrates Five Years of Essure Permanent Birth Control Procedure at The ACOG Annual Meeting 04/30/07   Conceptus Reports First Quarter Financial Results 04/17/07   Conceptus to Hold 2007 First Quarter Financial Results Conference Call April 30, 2007 03/29/07   Conceptus to Present at Suntrust Robinson Humphrey 36th Annual Institutional Conference 03/28/07   Conceptus Breaks Language Barrier by Offering Permanent Birth Control Informatino to a Growing Multi-ethnic Community 03/05/07   Conceptus To Present at the Cowen and Company 27th Annual Health Care Conference 02/27/07   Conceputs Amends Agreement Regarding Exercise of Call Option on International Partner 02/27/07   Conceptus Updates 2007 Financial Guidance 02/27/07   Conceptus Reports Record Fourth Quarter Financial Results 02/15/07   Conceptus Closes Additional $11.3 Million From Exercise of Over-allotment of Convertible Senior Notes 02/15/07   Conceptus to Hold 2006 Fourth Quarter Financial Results / 2007 Financial Guidance Conference Call Februrary 27, 2006 02/12/07   Conceptus Closes $75 Million Offering of Convertible Senior Notes 02/07/07   Conceptus Announces Pricing of $75 Million Convertible Senior Notes Offering 02/05/07   Conceptus Updates 2006 Financial Guidance Introduces 2007 Guidance 02/05/07   Conceptus Intends to Offer $75 Million of Convertible Senior Notes 2006 Press Releases 11/30/06   Conceptus to Present at the BMO Capital Markets Focus on Healthcare Conference 11/21/06   Studies Show Essure Procedure is Permanent Birth Control Option for Women Not Suitable for Tubal Ligation Surgery 11/16/06   Conceptus to Present at the 3rd Annual Lazard Life Sciences Investor Conference 11/02/06   Conceptus’ Permanent Birth Control Web Sites for Consumers and Healthcare Professionals Earn Excellence Awards 10/30/06   Conceptus to Present at CIBC World Markets 17th Annual Healthcare Investor Conference 10/26/06   Conceptus Named Fourth Fastest Growing Medical Equipment Company in Deloitte’s Technology Fast 500 Program 10/26/06   Conceptus Third Quarter Net Sales Double 10/20/06   Newly Trained Essure Physicians Achieve 94.6% Bilateral Placement Success 10/17/06   Conceptus to Present at C.E. Unterberg, Towbin Life Sciences Investor Conference 10/10/06   Conceptus to Hold 2006 Third Quarter Financial Results Conference Call on October 26, 2006 09/19/06   Conceptus to Present at UBS 2006 Global Life Sciences Investor Conference 09/12/06   Conceptus Announces Partnerships Now in Place with All Major Hysteroscope Manufacturers 07/25/06   Conceptus Reports Record $10 Million Second Quarter Net Sales 07/06/06   Conceptus to Hold 2006 Q2 Financial Results Conference Call on July 25, 2006 06/28/06   Conceptus Added to the Russell 3000 Index 05/08/06   New Studies on the Essure® Procedure Confirm Safety for High-risk Women 05/05/06   Study Shows Essure® Procedure In-office Placement Success 04/26/06   Conceptus Reports First Quarter Net Sales Up 106% 04/17/06   Conceptus to Hold 2006 First Quarter Financial Results Conference Call April 26, 2006 04/11/06   Conceptus to Present at the SunTrust 35th Annual Institutional Conference 02/15/06   CIGNA Now Covering the Essure Procedure 02/15/06   Conceptus Provides 2006 Financial Guidance 02/15/06   Conceptus Reports 4Q Financial Results 02/14/06   Essure Procedure Now Covered by Medicaid in New York, Texas and Wisconsin 01/10/06   Conceptus to Hold 2005 Fourth Quarter Financial Results/2006 Financial Guidance Conference Call February 15, 2006 2005 Press Releases 12/13/05   Conceptus Hires Patty Gray as Vice President, R&D and Operations 12/05/05   Conceptus to Present at Harris Nesbitt Focus on Healthcare Conference 11/09/05   New Data Confirms Successful Use of Essure® Permanent Birth Control in an Office Setting 11/01/05   Conceptus to Present at CIBC World Markets 16th Annual Healthcare Conference 10/27/05   Conceptus Reports Sales Up 94% in Third Quarter 10/12/05   Conceptus to Hold Q3 Financial Results Conference Call October 27, 2005 09/23/05   Positive Data Leads to FDA Approval for Early Termination of Essure Post-Approval Study 09/21/05   Conceptus to Present at UBS 2005 Global Life Sciences Conference 08/09/05   Conceptus Prices $23 Million Financing 08/05/05   Conceptus and Gynecare Terminate Agreement 07/27/05   Conceptus Reports Q2 Financial Results 07/18/05   Conceptus Received FDA Approval for Essure Four- and Five-Year Effectiveness 07/13/05   Conceptus to Hold Q2 Financial Results Conference Call July 27, 2005 07/13/05   Conceptus to Present at Adams Harkness’ 25th Annual Summer Seminar 07/12/05   Conceptus Reports Favorable Coverage Decision By UnitedHealthcare 07/11/05   Conceptus Preannounces Q2 Results – Net Sales Up 82%; Cash Burn Reduced 07/07/05   Conceptus Announces Key Partnerships with Major Hysteroscope Manufacturers to Increase In-Office Services 07/07/05   Conceptus’ Right of First Refusal Turned Down 05/31/05   Conceptus to Present at Pacific Growth Equities’ 2005 Life Sciences Growth Investor Conference 05/17/05   Conceptus' Essure® Procedure Focus of Multiple Abstracts and Posters Presentations at ACOG 04/26/05   Conceptus Reports Record Net Sales Up 63%, Files Updated Label Claims With FDA 04/14/05   Conceptus to Hold Q1 Financial Results Conference Call April 26, 2005 03/14/05   Conceptus Reports Fourth Quarter and Year-End Financial Results 03/04/05   Conceptus to Hold Q4 Financial Results Conference Call March 14, 2005 02/25/05   Conceptus Submits PMA Supplement to Support Essure® Four-and Five-Year Effectiveness 01/13/05   Conceptus Provides 2005 Financial Guidance, Reaffirms 2004 Guidance 2004 Press Releases 11/17/04   New Data Presented at AAGL Reveals Significant Cost-savings of Essure Over Tubal Ligation 11/08/04   Conceptus Reports Q3 Financial Results 11/04/04   New CPT Code Values Provided For Essure® Procedure 10/26/04   Conceptus to Hold Q3 Financial Results Conference Call November 8, 2004 10/12/04   Survey Reveals that Most Chicago Women are Unaware of Less Invasive Permanent Birth Control Option 10/01/04   Conceptus Reports Third and Fourth Quarter Financial Guidance 09/14/04   Conceptus Reports Humana to Cover Essure® in Physician Offices and Hospitals 07/27/04   Conceptus Reports Second Quarter Financial Results 07/27/04   Conceptus Reports Essure® Reimbursement Grows to 149 Million Covered Lives 07/27/04   Conceptus and GYNECARE to Begin Immediate Co-Promotion of Essure® and THERMACHOICE* Products to U.S. Obstetrician/Gynecologists 07/12/04   Conceptus to Hold Second Quarter Financial Results Conference Call July 27, 2004 06/14/04   Conceptus announces FDA approval of three-year effectiveness claim for Essure® 05/24/04   Essure® Featured on TV’s “Parenting and Beyond” 04/22/04   Conceptus Reports First Quarter 2004 Financial Results 04/15/04   Conceptus Received FDA Approval to Manufacture Essure® at Lower-cost Site in Mexico 04/07/04   Conceptus to Hold First Quarter Financial Results Conference Call April 22, 2004 04/01/04   Conceptus Hires Ric Cote as Vice President, Sales 03/30/04   CMS Issues New Reimbursement Code Covering Essure® Device 03/04/04   AMA Panel Agrees to Establish Category I CPT Code for Essure® 03/01/04   Essure Approved for use by Planned Parenthood Federation of America 02/26/04   Conceptus Revises 2004 Financial Guidance 02/26/04   Conceptus Completes $25.5 Million Financing 02/11/04   Conceptus Reports 4th Quarter and Annual Financial Results 02/03/04   Conceptus to Hold 4th Quarter Year-end Financial Results Conference Call February 11, 2004 2003 Press Releases 12/10/03   Conceptus Provides 2004 Financial and Operational Guidance 11/17/03   Conceptus names Gregory E. Lichtwardt Chief Financial Officer 11/04/03   Conceptus to Present at CIBC World Markets Annual Healthcare Conference 10/30/03   Conceptus Reports Third Quarter Financial Results 10/30/03   Conceptus enters Exclusive Co-Promotion Agreement with GYNECARE for Marketing Essure® and ThermaChoice in the U.S. 10/30/03   Conceptus Appoints Three New Directors 10/23/03   Conceptus to Hold Third Quarter Financial Results Conference Call October 30, 2003 10/23/03   Conceptus and Ovion, Inc. Settle Patent Litigation 08/05/03   Pivotal Clinical Trial Data on Conceptus’ Essure® Permanent Birth Control Procedure Published in Leading Ob/Gyn Journal 07/29/03   Conceptus Second Quarter Results Feature Net Sales Up 77% From First Quarter 07/22/03   Conceptus to Hold Second Quarter Financial Results Conference Call July 29, 2003 07/17/03   Australian Clinical Study Demonstrates Improved Placement Rate with New Coil Catheter for Conceptus’ Essure® System 06/26/03   Conceptus Reaches Key Milestone with Blue Cross/Blue Shield Coverage of the Essure™ Procedure 05/08/03   Conceptus Reports First Quarter Financial Results 04/29/03   Conceptus’ Essure™ System Now Available Nationwide 04/27/03   Conceptus Announces Appointment of Mark M. Sieczkarek as New Chief Executive Officer 02/26/03   Conceptus Reports Fourth Quarter and Full Year Financial Results 02/19/03   Conceptus to Hold Fourth Quarter and Year-End Financial Results Conference Call February 26, 2003 01/14/03   Conceptus Provides Update on Essure™ U.S. Launch and Physician Reimbursement 2002 Press Releases 11/26/02   Conceptus Announces CEO Succession Plan 11/04/02   FDA Grants Approval to Market Essure™ in the U.S. 08/15/02   Conceptus Responds to Patent Infringement Claim Made by Ovion, Inc. 07/25/02   Conceptus Reports Second Quarter Financial Results 07/22/02   FDA Advisory Committee Recommends Conceptus’ Essure™ for Approval 06/26/02   Conceptus Completes Public Offering 06/21/02   Conceptus Prices Follow-on Public Offering 05/29/02   Conceptus Files Registration Statement for Proposed Public Offering 05/23/02   PMA Granted Expedited Review Status and July Panel Meeting by FDA 05/07/02   New Conceptus Data Show Majority of Women Back to Full Regular Activities in Less Than One Day After Undergoing the Investigational Essure™ Permanent Birth Control Procedure 04/24/02   Conceptus Reports First Quarter Financial Results 04/22/02   Conceptus Submits Essure™ PMA to the FDA 04/17/02   Conceptus to Hold First Quarter Financial Results Conference Call April 24, 2002 03/18/02   Conceptus Accelerates Essure PMA Submission 02/25/02   Conceptus Appoints Steve Bowman Senior Vice President of Sales and Marketing 02/12/02   Conceptus Introduces Essure™ in Certain European Markets and in Canada 02/12/02   Conceptus to Hold Fourth Quarter Financial Results Conference Call February 26, 2002 02/12/02   Conceptus Reports Fourth Quarter and Annual Financial Results 2001 Press Releases 11/27/01   Conceptus Receives Canadian Approval to Market Essure™ 11/16/01   New Non-Surgical Option for Permanent Contraception on the Horizon Women Give 'Good' to 'Excellent' Rating to Procedure Experience 11/06/01   Conceptus Completes $30.8 Million Financing 08/29/01   Conceptus Names Dr. Marie-Helene Plais-Cotrel to Board of Directors 08/02/01   Conceptus Appoints Susan M. Aloyan Vice President of Regulatory Affairs 07/11/01   Conceptus Pivotal Trial Data Show 92 Percent of Women Return to Work in One Day or Less of Permanent Birth Control Procedure 05/04/01   Conceptus Appoints William H. Dippel Vice President of Operations 04/26/01   Conceptus Reports First Quarter Financial Results 04/21/01   Conceptus Completes $11.5 Million Financing 03/29/01   Conceptus Reports That Interim Pivotal Trial Data Confirms & Strengthens Encouraging Phase II Results 02/21/01   Conceptus Appoints Glen K. Furuta Chief Financial Officer 02/22/01   Conceptus Reports Fourth Quarter Financial Results 02/07/01   Conceptus Receives CE Mark for STOP™ 02/06/01   Conceptus Appoints Charles S. Carignan, M.D. Vice President of Clinical Research and Medical Affairs 01/03/01   Conceptus Announces Early Attainment of Patient Enrollment Goal for STOP Pivotal Trial Disclaimer The clinical information provided in these press releases is based on clinical testing of the current design of the Essure permanent birth control system only, and does not reflect clinical data from the prior discontinued designs. To learn more about the clinical testing of the current and discontinued designs, please see publicly available filings with the Securities and Exchange Commission available at this web site at the link entitled "SEC Filings." These press releases are provided for reference purposes only and Conceptus assumes no obligation to update, correct or otherwise modify any of these press releases. In order to view the most current information made available by Conceptus, we recommend that you view the most recent press release(s) and/or SEC filings.

Site Index | Contact Us | Privacy | Product Sites